Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stelitano

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Haematologica|January 4, 1998
The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemiaF Morabito, I Callea, G Console, et al.
Acta Haematologica|April 2, 2005
The CX3C chemokine fractalkine (CX3CL1) is detectable in serum of B cell chronic lymphocytic leukemia patients with lymph node involvementF Morabito, R A Merendino, G Penna, et al.
European Journal of Haematology|September 1, 1995
Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: long-term results of a randomized trialM Brugiatelli, B Jaksic, A Planinc-Peraica, et al.
Haematologica|April 6, 1999
Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 casesC Stelitano, F Morabito, M G Kropp, et al.
British Journal of Haematology|August 8, 1998
In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemiaF Morabito, C Stelitano, I Callea, et al.
Haematologica|March 7, 2000
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL)P G Gobbi, M L Ghirardelli, P Avanzini, et al.
British Journal of Haematology|December 3, 1999
Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcomeV Callea, F Morabito, B M Oliva, et al.
Haematologica|February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registryC Stelitano, L Baldini, C Pieresca, et al.
Bone Marrow Transplantation|December 6, 2005
The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL)F Morabito, C Stelitano, S Luminari, et al.
Haematologica|May 18, 1999
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL)G Longo, C Fiorani, S Sacchi, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Haematologica|January 4, 1998
The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemiaF Morabito, I Callea, G Console, et al.
Acta Haematologica|April 2, 2005
The CX3C chemokine fractalkine (CX3CL1) is detectable in serum of B cell chronic lymphocytic leukemia patients with lymph node involvementF Morabito, R A Merendino, G Penna, et al.
European Journal of Haematology|September 1, 1995
Treatment of chronic lymphocytic leukemia in early and stable phase of the disease: long-term results of a randomized trialM Brugiatelli, B Jaksic, A Planinc-Peraica, et al.
Haematologica|April 6, 1999
Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 casesC Stelitano, F Morabito, M G Kropp, et al.
British Journal of Haematology|August 8, 1998
In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemiaF Morabito, C Stelitano, I Callea, et al.
Haematologica|March 7, 2000
A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL)P G Gobbi, M L Ghirardelli, P Avanzini, et al.
British Journal of Haematology|December 3, 1999
Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcomeV Callea, F Morabito, B M Oliva, et al.
Haematologica|February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registryC Stelitano, L Baldini, C Pieresca, et al.
Bone Marrow Transplantation|December 6, 2005
The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL)F Morabito, C Stelitano, S Luminari, et al.
Haematologica|May 18, 1999
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL)G Longo, C Fiorani, S Sacchi, et al.
Pageof 3